BioLineRx (BLRX) Interest & Investment Income (2011 - 2025)
BioLineRx's (BLRX) quarterly Interest & Investment Income came in at $303000.0 in Q4 2025, down 10.09% year-on-year from $337000.0 in Q4 2024, and down 19.63% quarter-over-quarter from $377000.0 in Q3 2025.
BioLineRx (BLRX) Interest & Investment Income (2011 - 2025) Analysis & Trends
BioLineRx's Interest & Investment Income history runs 14 years deep, the most recent figure standing at $303000.0 for Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 10.09% year-over-year to $303000.0 in Q4 2025; TTM through Dec 2025 was $1.5 million, a 21.75% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 21.75% from the prior year.
- Interest & Investment Income declined to $303000.0 in Q4 2025 per BLRX's latest filing, from $377000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $779000.0 in Q4 2023 and bottomed at $52000.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $324500.0 (2023), against an average of $332800.0.
- Across the five-year window, Interest & Investment Income soared 1081.82% in 2021 and slumped 56.74% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $260000.0 in 2021, then surged by 68.46% to $438000.0 in 2022, then surged by 77.85% to $779000.0 in 2023, then slumped by 56.74% to $337000.0 in 2024, then slipped by 10.09% to $303000.0 in 2025.
- Per Business Quant, the three latest BLRX Interest & Investment Income figures stand at $303000.0 (Q4 2025), $377000.0 (Q3 2025), and $490000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | BioLineRx | 6.98 Bn | 6.98 Bn | 154,000.00 | 303,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 377,000.00 |
| Jun 30, 2025 | 490,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 337,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 535,000.00 |
| Mar 31, 2024 | 565,000.00 |
| Dec 31, 2023 | 779,000.00 |
| Sep 30, 2023 | 312,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Mar 31, 2023 | 537,000.00 |
| Dec 31, 2022 | 438,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 117,000.00 |